Latest News

The study builds on a growing body of research suggesting 3D mammography could offer benefits over 2D imaging.

That the biggest disparities were seen among women diagnosed with hormone receptor-positive tumors highlights the role racial disparities play in the mortality rates, said Dr. Eric Winer, director of the Yale Cancer Center. “In these cancers, people need to be on extended treatment with hormonal therapy for five years or more, which is often associated with out-of-pocket cost, so economics play a role,” Winer said.

Researchers say fewer false positives and the overall higher cancer detection rate is a win-win and shows DBT is not over-diagnosing cancers.

Stephanie Massaro, MD, MPH, participates in a Q&A in honor of Childhood Cancer Awareness Month.

Gene and cell therapies bring fresh hope to people with genetic disorders, but recovery can be complex and long-term support remains sparse.

“The concept of screening is to find dangerous things before they do dangerous things,” said Dr. Daniel Boffa, chief of thoracic surgery at Yale.

Dr. Pamela Kunz discusses "Advances in the Care of Neuroendocrine Tumors (NETs)."

News article about people living and working with cancer

In today's health headlines, WTNH discusses Ovarian Cancer Awareness Month with Yale Cancer Center gynecologic oncologist Dr. Elena Ratner.